$2.43 Million in Sales Expected for DURECT Co. (NASDAQ:DRRX) This Quarter

Wall Street analysts forecast that DURECT Co. (NASDAQ:DRRX – Get Rating) will post $2.43 million in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for DURECT’s earnings. The lowest sales estimate is $2.00 million and the highest is $2.85 million. DURECT posted sales of $2.21 million during the same […]

Related Keywords

Thomson Reuter ,Judithj Robertson ,Cowen Prime Advisors ,Geode Capital Management ,Securities Exchange Commission ,Healthcare Value Capital ,Zacks Investment Research ,Blackrock Inc ,Nasdaq ,Beirne Wealth Consulting Services ,Company Profile Get Rating ,Wall Street ,Get Rating ,Investment Research ,Director Judith ,Exchange Commission ,Prime Advisors ,Capital Management ,Wealth Consulting Services ,Durect ,Nasdaq Drrx ,Drrx ,Medical ,Ratings ,Consensus ,